Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy
========================================================================================================================================================================

* Aimilia Schina
* Zsofia Sztupinszki
* Inge Marie Svane
* Zoltan Szallasi
* Göran Jönsson
* Marco Donia